In overweight patients with type 2 diabetes, the fibroblast growth factor 21 (FGF21) analog showed decreased plasma lipids, increased blood adiponectin levels, and significantly decreased body weight [4]. The gene discussed is FGF21; the disease is type 2 diabetes mellitus.